Your browser doesn't support javascript.
loading
Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
Fernandez-Sojo, Jesus; Cid, Joan; Azqueta, Carmen; Valdivia, Elena; Martorell, Lluis; Codinach, Margarita; Marsal, Julia; Mussetti, Alberto; Esquirol, Albert; Trabazo, Maria; Benitez, Maria Isabel; Ferra, Christelle; Fox, Maria Laura; Linares, Mónica; Alonso, Eva; García-Rey, Enric; García-Muñoz, Nadia; Medina, Laura; Castillo-Flores, Nerea; Vall-Llovera, Ferran; Garcia, Antoni; Pinacho, Asuncion; Talarn, Carme; Arroba, Jose Garcia; Coll, Rosa; Santos, Mireia; Valero, Oliver; Carreras, Enric; Lozano, Miquel; Querol, Sergio.
Afiliação
  • Fernandez-Sojo J; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain. jefernandez@bst.cat.
  • Cid J; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain. jefernandez@bst.cat.
  • Azqueta C; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis ICMHO, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Valdivia E; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain.
  • Martorell L; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Codinach M; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain.
  • Marsal J; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Mussetti A; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain.
  • Esquirol A; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Trabazo M; Cell Laboratory, Banc de Sang i Teixits, Barcelona, Spain.
  • Benitez MI; Pediatric Hematology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Ferra C; Adult Hematology Department, Institut Catala d'Oncologia-Hospitalet, Barcelona, Spain.
  • Fox ML; Adult Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukemia Research Institute, Universitat Autònoma of Barcelona, Barcelona, Spain.
  • Linares M; Pediatric Hematology Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Alonso E; Pediatric Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • García-Rey E; Adult Hematology Department, Institut Català d'Oncologia-Badalona, Barcelona, Spain.
  • García-Muñoz N; Adult Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Medina L; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Castillo-Flores N; Banc de Sang i Teixits, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Vall-Llovera F; Banc de Sang i Teixits, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Garcia A; Banc de Sang i Teixits, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Pinacho A; Banc de Sang i Teixits, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Talarn C; Banc de Sang i Teixits, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Arroba JG; Banc de Sang i Teixits, Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Coll R; Adult Hematology Department, Hospital Mutua de Terrassa, Terrassa, Spain.
  • Santos M; Adult Hematology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Valero O; Banc de Sang i Teixits, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Carreras E; Adult Hematology Department, Institut Català d'Oncologia-Tarragona, Tarragona, Spain.
  • Lozano M; Banc de Sang i Teixits, Hospital Universitari Joan XXlll, Tarragona, Spain.
  • Querol S; Adult Hematology Department, Institut Catala d'Oncologia-Girona, Girona, Spain.
Bone Marrow Transplant ; 57(8): 1341-1343, 2022 08.
Article em En | MEDLINE | ID: mdl-35614316
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue Periférico / Linfoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue Periférico / Linfoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article